[Cytogenetic indicators of genotoxicity in subjects occupationally exposed to antineoplastic drugs]. 1996

A Forni, and S Bonatti, and E Merler
Istituto di Medicina del Lavoro, Clinica del Lavoro L. Devoto, Università degli Studi di Milano.

The paper reviews the main characteristics of the cytogenetic indicators most frequently used in monitoring early biological effects in groups exposed to genotoxic agents, i.e. chromosome aberrations (CA), sister chromatid exchanges (SCE) and micronuclei (MN) in lymphocytes. The results of the numerous studies on CA and/or SCE performed on hospital or industry personnel potentially exposed to antineoplastic drugs are conflicting, probably due to the different degrees of exposure in different occupational settings, to different sensitivity of the indicators or to their different persistence. However, the studies carried out on groups of subjects who have always worked in protected conditions have given negative results for all indicators.

UI MeSH Term Description Entries
D008505 Medical Staff, Hospital Professional medical personnel approved to provide care to patients in a hospital. Attending Physicians, Hospital,Hospital Medical Staff,Physicians, Junior,Registrars, Hospital,Attending Physician, Hospital,Hospital Attending Physician,Hospital Attending Physicians,Hospital Medical Staffs,Medical Staffs, Hospital,Hospital Registrar,Hospital Registrars,Junior Physician,Junior Physicians,Physician, Junior,Registrar, Hospital,Staff, Hospital Medical,Staffs, Hospital Medical
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D004345 Drug Industry That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function. Industries, Pharmaceutic,Industry, Drug,Industry, Pharmaceutic,Industry, Pharmaceutical,Pharmaceutical Industry,Drug Industries,Industries, Drug,Industries, Pharmaceutical,Pharmaceutic Industries,Pharmaceutic Industry,Pharmaceutical Industries
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D016273 Occupational Exposure The exposure to potentially harmful chemical, physical, or biological agents that occurs as a result of one's occupation. Exposure, Occupational,Exposures, Occupational,Occupational Exposures

Related Publications

A Forni, and S Bonatti, and E Merler
January 2013, Igiene e sanita pubblica,
A Forni, and S Bonatti, and E Merler
February 2000, Chemosphere,
A Forni, and S Bonatti, and E Merler
August 2015, International archives of occupational and environmental health,
A Forni, and S Bonatti, and E Merler
January 1982, La Medicina del lavoro,
A Forni, and S Bonatti, and E Merler
January 1991, American journal of industrial medicine,
A Forni, and S Bonatti, and E Merler
January 1992, Lijecnicki vjesnik,
A Forni, and S Bonatti, and E Merler
January 2012, Toxicology international,
A Forni, and S Bonatti, and E Merler
January 2005, Epidemiologia e prevenzione,
A Forni, and S Bonatti, and E Merler
January 2004, Magyar onkologia,
A Forni, and S Bonatti, and E Merler
January 1994, International archives of occupational and environmental health,
Copied contents to your clipboard!